Molecular identification of adenovirus sequences: a rapid scheme for early typing of human adenoviruses in diagnostic samples of immunocompetent and immunodeficient patients.
Precise typing of human adenoviruses (HAdV) is fundamental for epidemiology and the detection of infection chains. As only few of the 51 adenovirus types are associated with life- threatening disseminated diseases in immunodeficient patients, detection of one of these types may have prognostic value and lead to immediate therapeutic intervention. A recently published molecular typing scheme consisting of two steps (sequencing of a generic PCR product closely adjacent to loop 1 of the main neutralization determinant epsilon, and for species HAdV-B, -C, and -D the sequencing of loop 2 [Madisch et al., 2005]) was applied to 119 clinical samples. HAdV DNA was typed unequivocally even in cases of culture negative samples, for example in immunodeficient patients before HAdV causes high virus loads and disseminated disease. Direct typing results demonstrated the predominance of HAdV-1, -2, -5, and -31 in immunodeficient patients suggesting the significance of the persistence of these viruses for the pathogenesis of disseminated disease. In contrast, HAdV-3 predominated in immunocompetent patients and cocirculation of four subtypes was demonstrated. Typing of samples from a conjunctivitis outbreak in multiple military barracks demonstrated various HAdV types (2, 4, 8, 19) and not the suspected unique adenovirus etiology. This suggests that our molecular typing scheme will be also useful for epidemiological investigations. In conclusion, our two-step molecular typing system will permit the precise and rapid typing of clinical HAdV isolates and even of HAdV DNA in clinical samples without the need of time-consuming virus isolation prior to typing.
Madisch
Ijad
I
Institut für Virologie, Medizinische Hochschule Hannover, Hannover Germany.
Wölfel
Roman
R
Harste
Gabi
G
Pommer
Heidi
H
Heim
Albert
A
D000256:Adenoviridae / Q000145:classification / Q000235:genetics* / Q000302:isolation & purification*; D000257:Adenoviridae Infections / Q000175:diagnosis* / Q000453:epidemiology / Q000276:immunology / Q000821:virology; D000956:Antigens, Viral / Q000235:genetics; D036022:Capsid Proteins / Q000235:genetics; D045744:Cell Line, Tumor; D003231:Conjunctivitis / Q000453:epidemiology / Q000821:virology; D004279:DNA, Viral / Q000235:genetics*; D004196:Disease Outbreaks; D005858:Germany / Q000453:epidemiology; D006801:Humans; D007121:Immunocompetence; D016867:Immunocompromised Host; D008889:Military Personnel; D016133:Polymerase Chain Reaction; D014773:Virology / Q000379:methods*
D000956:Antigens, Viral; D036022:Capsid Proteins; D004279:DNA, Viral; C018315:hexon capsid protein, Adenovirus